4th Edition of International Heart Congress
June 22-24,2026 | Hybrid Event
Angiotensin Receptor Blockers
Angiotensin Receptor Blockers (ARBs) play a crucial role in the field of cardiovascular medicine by targeting the renin-angiotensin-aldosterone system. These medications, also known as angiotensin II receptor antagonists, work by blocking the action of angiotensin II on specific receptors, thereby dilating blood vessels and reducing the workload on the heart. ARBs are commonly prescribed to manage conditions such as hypertension, heart failure, and diabetic nephropathy. By modulating the effects of angiotensin II, ARBs contribute to blood pressure regulation and the overall well-being of individuals with cardiovascular concerns. Their distinct mechanism of action and efficacy make ARBs a valuable class of drugs in the therapeutic arsenal against cardiovascular diseases, offering patients a targeted and effective approach to managing their health.
Yong Xiao Wang
Albany Medical College, United States
Ahdy Wadie Helmy
Indiana University School of Medicine, United States
Narendra Kumar
HeartbeatsZ Academy, United Kingdom
Desislava Doycheva
Loma Linda University, United States
Yong Xiao Wang
Albany Medical College, United States
Uwe Peter Tigor
Auxilius Pharma, United States
Ishan Abdullah
George Washington University School of Medicine and Health Sciences, United StatesSubmit your abstract Today
Title : Novel mechanisms and new therapeutics for right heart failure in pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Movement is medicine
Steve Cohen, Medvesta Hypnosis Healthcare, United States
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Fats of life, the skinny on novel lipid therapies beyond statins
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain
Title : Cardiovascular nanomedicine: Stopping strokes, unclogging arteries and restoring heart function
Thomas J Webster, Hebei University of Technology, China